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Editorial on the Research Topic
Nucleic Acid-Associated Inflammation
Inflammatory responses are essential to maintain organismal homeostasis and are typically induced
when autonomous defenses are impaired. For instance, inflammation can be engaged in response to
tissue damage or exposure to a variety of agents, including pathogenic microorganisms such as
viruses and bacteria as well as toxins and xenobiotics. Sensing of inflammatory agents largely relies
on the recognition of pathogen-associated molecular patterns (PAMPs), including microbe-
associated molecular patterns (MAMPs), through pattern recognition receptors (PRRs) (1).
Endogenous factors that are present in an aberrant location (e.g. cytoplasmic nucleic acid or
extracellular ATP), and/or in a disproportionate abundance, can also activate PRRs and are
commonly known as damage-associated molecular patterns (DAMPs) (2). Upon PAMPs or
DAMPs recognition, PRRs coordinate an early response of the host to endogenous or exogenous
threats that prime the host for the activation of adaptive immunity (Okude et al.) (3).
Given the central role of PRRs in the control of invading pathogens and endogenous threats, it is
not surprising that genetic or etiological alterations of inflammation foster a wide range of human
pathologies. Underscoring this concept, the persistent dysregulation of nucleic acid-associated
inflammatory pathways has been associated with the development of chronic liver diseases. The two
main etiology agents that are linked with these liver pathologies are hepatitis B virus (HBV) and
hepatitis virus C (HPC). These viruses have distinct genomes and viral life cycles but can both repress
innate anti-viral defenses through common mechanisms. These strategies are being discussed in our
Research Topic “Nucleic Acid-Associated Inflammation” by Roca Suarez et al., as well as Xu et al.
Innate immunity largely relies on the recognition of evolutionarily conserved structures that can be
identified via comparative analyses of innate immune responses, from biological models (zebrafish
and mouse) to human. This underscores the existence of tissue- and species- specificities, and is
discussed in six reviews of the Research Topic which cover various aspects, ranging from the role of
transposable elements to the limitations of in vivomodels and provides cues towards the development
of high content therapeutic strategies in relevant physiological models (Jacquet et al., Jami et al.,
Magnani et al., Rutherford et al., Sullivan et al., Verrier et al.).
However, despite major advances in the field of innate immunity to identify the pathways involved in
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regulated in respect to various nucleic acid substrates and tissue
insults. In this special Research Topic, key opinion leaders in the
field offer an overview of (1) the major molecular and cellular
aspects of nucleic acid sensing across species; (2) the complexity of
innate and adaptive immune responses and their key role in the
maintenance of tissue homeostasis; and (3) the intricate connections
between deregulated nucleic acid sensing machinery and human
disease. For instance, reviews by Santa et al. and by Kumar give a
comprehensive overview of the regulatory circuitries of nucleic acid-
sensing pathways.
Even though nucleic acid-associated inflammation is the first
line of defense of the host, activation of innate immunity is not
always guaranteed. Indeed, microbes and malignant cells have
developed a variety of strategies to prevent inflammation, in
order to counteract the host response or escape the induction of
anti-tumor immunity (4). Supporting this concept, evidence
demonstrates that nucleic acid sensing is critical to generate
radiation-induced anti-tumor immunity (5). Such responses
result from the recognition of mitochondrial DNA in irradiated
tumor cells by the cyclic GMP-AMP synthase (cGAS) sensor of
cytosolic DNA (6). Since then, efforts in uncovering the
adjuvanticity of radiation therapy from multiple types of ionizing
radiations have pointed towards the role of DNA damage response
and cytosolic DNA detection in priming anti-tumor responses.
Some of the current views of how genotoxic stress crosstalk with
innate immune responses and anti-tumoral immunity are
summarized in reviews by Constanzo et al. and by Taffoni et al.
Regulating abnormal nucleic acid sensing is emerging as a potent
strategy against inflammatory diseases. Thus, PRRs and their
downstream effectors have become attractive targets for the
identification of biomarkers and the development of therapeutic
agents with broad-range efficacy against inflammatory disorders.
Review by Hemphill et al. from this Research Topic is discussing the
therapeutic potential of the three-prime repair exonuclease 1
(TREX1) targetingasanovel immunotherapystrategyagainst cancer.
In conclusion, each one of the reviews and articles presented
in Nucleic Acid-Associated Inflammation focuses on one specific
aspect of nucleic acid sensing, encompassing signaling,Frontiers in Immunology | www.frontiersin.org 2regulation, interspecies specificities, and pathology relevance.
The Research Topic is equally addressed to expert investigators
who may wish to extend their knowledge on inflammation,
innate and nucleic acid immunity, and to newcomers to this
exciting and quickly progressing field of investigation.AUTHOR CONTRIBUTIONS
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